Investments
7Portfolio Exits
1Partners & Customers
8Service Providers
1About Cochlear
Cochlear provides implantable hearing solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers cochlear implants, including Nucleus 7 and Kanso sound processors; Carina middle-ear implants and accessories; and Baha bone conduction implants, such as Baha attract system, Baha connect system, Baha softband, Baha soundarc, Baha 5 sound processor, Baha 5 power, Baha 5 superpower, other sound processors, and wireless accessories. It also provides Cochlear true wireless devices comprising mini microphones, phone clips, and TV streamers; and Cochlear Vistafix bone-anchored facial prosthetic solutions to enhance the attachment and cosmetic outcome of facial prostheses.
Cochlear Headquarter Location
1 University Avenue Macquarie University
Macquarie University, New South Wales, 2109,
Australia
61 2 9428 6555
Expert Collections containing Cochlear
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Find Cochlear in 1 Expert Collection, including Medical Devices.
Medical Devices
3,383 items
Companies that received PMA from the FDA since 2014. Companies tagged as #FDAPMA
Cochlear Web Traffic
Cochlear Rank
Latest Cochlear News
Aug 10, 2022
Key Companies Compiled in the Global Hearing Aids Market Research Report by Kenneth Research Include Sonava, Demant A/S, GN Store Nord A/S, WS Audiology A/S, Starkey Laboratories, Inc., MED-EL Medical Electronics, Cochlear Ltd., RION CO., LTD., Audina Hearing Instruments, Inc., and others. Key Companies Compiled in the Global Hearing Aids Market Research Report by Kenneth Research Include Sonava, Demant A/S, GN Store Nord A/S, WS Audiology A/S, Starkey Laboratories, Inc., MED-EL Medical Electronics, Cochlear Ltd., RION CO., LTD., Audina Hearing Instruments, Inc., and others.
Cochlear Investments
7 Investments
Cochlear has made 7 investments. Their latest investment was in Epiminder as part of their Bridge on March 3, 2022.
Cochlear Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
3/15/2022 | Bridge | Epiminder | $11.5M | No | 1 | |
10/14/2021 | Corporate Minority | |||||
8/26/2021 | Series A | |||||
10/9/2020 | Series A | |||||
11/12/2018 | Series C |
Date | 3/15/2022 | 10/14/2021 | 8/26/2021 | 10/9/2020 | 11/12/2018 |
|---|---|---|---|---|---|
Round | Bridge | Corporate Minority | Series A | Series A | Series C |
Company | Epiminder | ||||
Amount | $11.5M | ||||
New? | No | ||||
Co-Investors | |||||
Sources | 1 |
Cochlear Portfolio Exits
1 Portfolio Exit
Cochlear has 1 portfolio exit. Their latest portfolio exit was Nyxoah on September 09, 2020.
Cochlear Acquisitions
2 Acquisitions
Cochlear acquired 2 companies. Their latest acquisition was Oticon Medical on April 27, 2022.
Date | Investment Stage | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Total Funding | Note | Sources |
|---|---|---|---|---|---|---|
4/27/2022 | Acquired | 3 | ||||
5/11/2017 |
Date | 4/27/2022 | 5/11/2017 |
|---|---|---|
Investment Stage | ||
Companies | ||
Valuation | ||
Total Funding | ||
Note | Acquired | |
Sources | 3 |
Cochlear Partners & Customers
8 Partners and customers
Cochlear has 8 strategic partners and customers. Cochlear recently partnered with GN Group on November 11, 2018.
Date | Type | Business Partner | Country | News Snippet | Sources |
|---|---|---|---|---|---|
11/8/2018 | Partner | Denmark | The deepening of this relationship includes joint research and development , shared technology and strengthened global Smart Hearing Alliance commercial collaboration between Cochlear Limited and GN Hearing , the hearing aid division of the GN Hearing . | 6 | |
4/12/2018 | Licensor | ||||
7/26/2017 | Partner | ||||
12/22/2016 | Partner | ||||
1/1/2015 | Partner |
Date | 11/8/2018 | 4/12/2018 | 7/26/2017 | 12/22/2016 | 1/1/2015 |
|---|---|---|---|---|---|
Type | Partner | Licensor | Partner | Partner | Partner |
Business Partner | |||||
Country | Denmark | ||||
News Snippet | The deepening of this relationship includes joint research and development , shared technology and strengthened global Smart Hearing Alliance commercial collaboration between Cochlear Limited and GN Hearing , the hearing aid division of the GN Hearing . | ||||
Sources | 6 |
Cochlear Service Providers
1 Service Provider
Cochlear has 1 service provider relationship
Service Provider | Associated Rounds | Provider Type | Service Type |
|---|---|---|---|
Acquired | Investment Bank | Financial Advisor |
Service Provider | |
|---|---|
Associated Rounds | Acquired |
Provider Type | Investment Bank |
Service Type | Financial Advisor |
Partnership data by VentureSource
Cochlear Team
11 Team Members
Cochlear has 11 team members, including former Chief Executive Officer, President, Ron West.
Name | Work History | Title | Status |
|---|---|---|---|
Ron West | Chief Executive Officer, President | Former | |
David Morris | President, Senior Vice President | Former | |
John Parker | NICTA | Chief Technology Officer | Former |
Peter C Weber | Chief Medical Officer | Former | |
Lisa Emerson | Senior Vice President | Former |
Name | Ron West | David Morris | John Parker | Peter C Weber | Lisa Emerson |
|---|---|---|---|---|---|
Work History | NICTA | ||||
Title | Chief Executive Officer, President | President, Senior Vice President | Chief Technology Officer | Chief Medical Officer | Senior Vice President |
Status | Former | Former | Former | Former | Former |
You May Also Like
Zounds designs, manufactures, and markets high performance hearing aids for use with mild, moderate, and moderate/severe hearing impairments. Zounds' goal is to offer a portfolio of hearing aids and wireless devices that provide the world's best performing technology at an affordable price to anyone with a mild, moderate, or moderate/severe hearing loss.
Audigence has developed patented software that better tunes cochlear implant and hearing aids for clearer speech recognition in hearing-impaired individuals.
VAST Audio leverages its acoustics platform technology to develop DSP technologies involving the application of advanced sensory processing techniques to 3D hearing devices. The Company is developing a spatial hearing aid to effectively support listening in both noisy and quiet environments. The hearing aid is based on the company's Completely-in-Canal (CIC) earphone and aims to provide the perceptual basis for segregating talkers in noisy environments and will lead to vast improvement in speech segregation and intelligibility.
Accord Biomaterials aims to develop nitric oxide generating coatings for blood-contacting medical devices. Their coatings address serious complications related to clotting and altered healing, improving performance and reducing total costs of critical medical device interventions.
Kyphon develops and markets medical devices designed to restore spinal function using minimally invasive technologies. The company's KyphX(R) line of products is used in balloon kyphoplasty, a minimally invasive procedure to treat spinal fractures caused by osteoporosis or cancer. More information about the company can be found at www.kyphon.com.
The GN Group is a global leader in intelligent audio solutions that let you hear more, do more and be more than you ever thought possible. Its unique portfolio of medical, professional & consumer audio solutions – and the deep research & development expertise behind this range of products gives our brands unprecedented advantages in the med-tech, hearables and intelligent audio field.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.